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EDITORIAL
Clinical, Experimental and Modeling Studies in AD/HD
This issue ofNeural Plasticity covers advances
in our understanding of the basic processes that
underpin the psycho-patho-physiology ofAttention
Deficit Hyperactivity Disorder (AD/HD). The
papers are divided into three sections: human
studies with clinical populations, animal model
studies, and mathematical modeling studies.
The clinical studies focus on the issue ofneuro-
psychological and developmental heterogeneity in
AD/HD. They attempt to identify some of the
potentially multiple patho-physiological pathways
to the disorder. The papers by Dalen and colleagues
and Stevenson and colleagues provide evidence for
the existence of at least two neuropsychological
quite distinct routes to the expression of AD/HD
symptoms, a motivational pathway associated with
intolerance for delay and a cognitive pathway
associated with executive dysfunction. The paper
by Sonuga-Barke highlights the importance of
taking account of the role of this heterogeneity in
AD/HD when developing new and potentially
more effective non-pharmacological therapeutic
options. The paper by Auerbach provides preliminary
evidence for the way that developmental
trajectories toward AD/HD are l.i.kely to be shaped
by the interactions of genetic and environmental
factors operating in early environments. All these
papers challenge the view that AD/HD is a single
psycho-patho-physiological entity, understandable
in terms of simple deficits. On the other hand,
animal studies focus on the dopamine (DA) and
norepinephrine (NE) systems, their interactions in
the control of executive functions and sustained
attention. They pertain to in vivo and in vitro
observations, using techniques like behavior,
pharmacology, molecular biology, morphometry,
microdialysis, electrophysiology, and cell culture.
Volpicelli et al. analyze the mechanisms involved
in the acquisition of the dopamine phenotype, that
is important for the developmental theories of
AD/HD. Masuo et al. investigate motor activity,
catecholamine content, gene expression alterations
in the striatum and midbrain and TH1
immunoreactivity in rats made hyperactive by
postnatal 6-OH DA and endocrine disruptors.
Carboni et al. review in vivo and in vitro the
dopamine system of animal models of AD/HD.
Viggiano et al. review he effects ofNET blockers
and the NE-DA interaction in animal models of
ADHD. These studies address the complexity of
events that are involved in the expression of the
dopamine phenotype, their susceptibility to
environmental stressors, plasticity, and interactions
in adult animals.
Finally, computational modeling attempts have
been made based on the wealth of data emerging
from clinical and experimental studies. For instance,
Williams and Taylor explore AD/HD in terms of
the temporal difference model that accounts for the
prediction error by dopamine cell activity.
Viggiano et al. review changes in the dopamine
systems in hyperactive animals and model them by
kinetic analysis. These attempts in modeling a
human syndrome are highly promising for future
development ofthis interdisciplinary approach.
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